MedTrace Logo

Mobile App for Risk Reduction of Type 2 Diabetes

NCT06117098 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-11-03

No results posted yet for this study

Summary

The aim of this feasibility study is to investigate whether a full scale RCT on the efficacy of a mobile app for risk reduction on type 2 diabetes can be conducted in the way it is planned or whether it needs to be modified. This will be investigated through a feasibility study (small scale RCT) on the efficacy of mobile technology on risk reduction of type 2 diabetes.

Conditions

  • Prediabetic State

Interventions

DEVICE

Mobile application

Individual lifestyle intervention via an mobile application

BEHAVIORAL

Group-based lifestyle intervention at a Healthy Lifestyle Centre + mobile application"

Group-based lifestyle intervention at a Healthy Lifestyle Centre + mobile application"

BEHAVIORAL

Group-based lifestyle intervention

Group-based life style intervention at a Healthy Lifestyle Centre (ususal care)

Sponsors & Collaborators

  • Oslo Metropolitan University

    lead OTHER

Principal Investigators

  • Birgitta Blakstad Nilsson, Phd · OsloMet

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-02
Primary Completion
2023-12-31
Completion
2024-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06117098 on ClinicalTrials.gov